Episode Details

Back to Episodes
#211 | The NUMBER ONE Reason Clinically Proven MedTech Products Still Fail

#211 | The NUMBER ONE Reason Clinically Proven MedTech Products Still Fail

Published 1 month, 2 weeks ago
Description

Have you ever wondered why a clinically proven MedTech product can achieve regulatory approval, generate positive feedback, and still fail commercially?

Many clinician founders believe that strong clinical evidence is enough to drive adoption. Unfortunately, healthcare doesn't work that way. In this episode, Hakeem speaks with Holly Miller about why adoption is engineered long before launch and how behavioural science, market conditioning, and stakeholder alignment help transform innovative MedTech products from interesting ideas into the new standard of care.

Listeners will discover:

  • Why clinical evidence alone rarely changes behaviour or guarantees adoption
  • How to move your MedTech product from a "nice-to-have" to a "must-have" for the right audience
  • The practical adoption strategies that successful MedTech companies use before launching into the market

Play this episode now to discover how to engineer adoption before launch and give your MedTech product the best chance of achieving commercial success and becoming the new standard of care.

Book a 30min Healthcare Export Accelerator discovery call

Message me via DM on Linkedin

This podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

Visit Holleys website for launch assessment belaunchready.com

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us